Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer

por Erselcan, T, Kairemo, K J A, Wiklund, T A, Hernberg, M, Blomqvist, C P, Tenhunen, M, Bergh, J, Joensuu, H
Publicado 2000